Device Trial Radar · NCT07010354
An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow
Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Aug 8, 2025
Primary completion
Dec 31, 2027
Study completion Dec 31, 2031
Sponsor
- Lead sponsor
- Bentley InnoMed GmbHNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- KANDO Research
- First posted
- Jun 8, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This international, observational multi-centre study of the device BFI will monitor technical success of the implantation, data regarding clinical performance, clinical benefit, as well as potential unknown side effects pursuant to the Intended Purpose.
Conditions
- Iliac Artery Stenosis
- Iliac Artery Occlusion
Interventions
StentingDevice
Endovascular treatment of stenosed or occluded iliac arteries: Permanent intraluminal placement of a covered stent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary patency rateTime frame: 12 months
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
AZORG
Aalst, Belgium · Recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.